BONTAC: Transforming Lives with Cutting-Edge Biotechnology Products

BONTAC Bio-Engineering (Shenzhen) Co., Ltd., established in 2012, has emerged as a leading high-tech enterprise at the forefront of biotechnology products innovation. With a core focus on enzyme catalysis, BONTAC seamlessly integrates research and development, production, and sales to deliver a diverse range of products. From coenzymes and natural products to sugar substitutes, cosmetics, and medical intermediates, BONTAC is committed to revolutionizing various industries.

Leading the Global NMN Industry

BONTAC has cemented its position as the global leader in the NMN (Nicotinamide Mononucleotide) industry. With the distinction of being the first company in China to employ whole-enzyme catalysis technology, BONTAC has set new standards in biotechnical advancements. Their coenzyme products find extensive applications in the health, medical and beauty, green agriculture, biomedicine, and other sectors. BONTAC’s relentless pursuit of independent innovation is evidenced by their impressive portfolio of over 170 invention patents.

Driving Collaborative Innovation

BONTAC actively undertakes government-funded key technology projects at both provincial and municipal levels. Their pivotal contribution to the field of biotechnology is further exemplified by the establishment of the first coenzyme engineering technology research center in Guangdong Province, China. This notable institution serves as a hub for research capabilities and fosters collaborative relationships with esteemed academic institutions such as the Institute of Chemistry, Chinese Academy of Sciences, and Peking University Shenzhen Graduate School.

A Stellar Team of Experts

BONTAC owes its success to a team of exceptional professionals. With over 35 dedicated individuals, including 5 PhDs and 10 masters, BONTAC combines academic excellence with industry experience. The recruitment and cultivation of top talents in Shenzhen, including participants in the esteemed Peacock Program, demonstrate BONTAC’s commitment to assembling a team of experts. Collaborative partnerships with renowned research institutes further enhance BONTAC’s capabilities, enabling them to remain at the forefront of biotechnical research and development.

Conclusion

BONTAC Bio-Engineering (Shenzhen) Co., Ltd. stands as a trailblazer in the field of biotechnology products, driven by a passion for innovation, sustainability, and superior-quality products. With a diverse range of offerings and a focus on NMN production, BONTAC is revolutionizing industries such as health, cosmetics, and biomedicine. Their commitment to independent innovation, collaborative partnerships, and a highly skilled team of experts ensures that BONTAC remains at the forefront of biotechnical advancements.

About Alex

Check Also

廣汽埃安AION V:智能自動駕駛技術的安全先行者

隨著自動駕駛技術的進步,越來越多的汽車製造商投入到智能車的研發與生產中。廣汽埃安的AION V在香港市場的推出,不僅代表了技術的創新,更在主動安全系統方面設置了新的行業標準。本文將深入探討AION V在主動安全技術上的應用,並分析其對乘客安全的重要性。 主動安全系統的重要性 在當前的汽車市場中,主動安全已成為衡量智能無人駕駛車輛先進性的重要指標。主動安全系統不僅能夠在發生潛在碰撞時警告駕駛員,還能在必要時自動採取行動,以防止事故的發生。這類系統的核心在於預防事故,而非僅僅在事故發生後減輕後果。 AION V的主動安全技術 廣汽AION V裝配了一系列高端的主動安全技術,旨在提供全方位的駕駛安全保障。這些技術包括: – 自動緊急制動系統(AEB):當系統檢測到前方有碰撞風險時,會自動啟動煞車,以減少事故的可能性。這一功能在城市駕駛中尤為重要,可以有效預防因前方突然剎車或障礙物引起的追尾事故。 – 車道保持輔助系統(LKA):這一系統能夠檢測車輛是否偏離車道,並自動調整方向,幫助駕駛員保持在車道中央,特別是在高速公路長途駕駛中,這一功能能夠顯著提升行車安全。 – 盲點檢測系統:這一系統能夠警告駕駛員車側及後方的盲點區域內是否有其他車輛,防止在變換車道時發生碰撞。 …

Leave a Reply

Your email address will not be published. Required fields are marked *